Citigroup Upgrades Mindray Medical to Buy

Symbols: MR
Tags: Citigroup
Share

Citigroup has upgraded Mindray Medical (NYSE: MR) from Neutral to Buy and has raised the price target from $29 to $31.


 
 
< Previous
End-of-Day Market Summary for January 6, 2012
Next >
Brean Murray Upgrades Fossil to Buy
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust